Stockscreener 앱 받기
42.96
7.05%
2.83
시간 외 거래:
42.52
-0.44
-1.02%
Vera Therapeutics Inc 주식(VERA)의 최신 뉴스
US FDA approves Vera's kidney disease drug - Reuters
Vera Therapeutics (NASDAQ:VERA) stock up; Trutakna approval shifts attention to Q3 kidney data - TechStock²
Vera Therapeutics wins first FDA approval with kidney disease drug - The Business Journals
Why Is Vera Therapeutics Stock Gaining Tuesday? - Benzinga
VERA Stock Holds Gains As CEO Trims Stake In Form 4 Sale - StocksToTrade
Vera Therapeutics gains FDA nod for TRUTAKNA launch - TipRanks
Vera Therapeutics secures FDA approval for TRUTAKNA - grafa.com
Vera gains after FDA nod for kidney disease therapy - Seeking Alpha
FDA grants accelerated approval to Vera Therapeutics (NASDAQ: VERA) drug TRUTAKNA - Stock Titan
FDA approves Vera Therapeutics kidney disease treatment - STAT
Vera Therapeutics Receives FDA Accelerated Approval for - GlobeNewswire
Vera’s TRUTAKNA wins FDA accelerated approval for kidney disease - Stock Titan
FDA approves Vera’s dual-target Trutakna, setting up IgAN market battle with Novartis, Otsuka - Fierce Pharma
Vera’s Trutakna wins FDA nod as first dual inhibitor for IgAN - BioWorld News
Vera Therapeutics outlines its kidney disease strategy as a clinical-stage biotech - AD HOC NEWS
VERA Stock Surges After Drug To Treat Rare Kidney Disease Gets FDA Approval – Retail Sees The Move As Catalyst For Vera Therapeutics - Stocktwits
Vera Therapeutics stock rises ahead of FDA decision - Investing.com
'I got back to living my normal life': How Vera Therapeutics' drug renewed a kidney patient ahead of FDA test - The Business Journals
Vera Therapeutics Jumps 9% as FDA Decision on Kidney Drug Looms - finance.biggo.com
What's Going on with Vera Therapeutics Stock on Monday? - Benzinga
Vera Therapeutics Shares Climb Ahead of FDA Decision on Atacicept (VERA) - Yahoo Finance
Scilex, Vera Therapeutics rise premarket; Strategy gains - Yahoo Finance
Scilex, Vera Therapeutics rise premarket; Strategy gains By Investing.com - Investing.com South Africa
Vera Therapeutics stock rises ahead of FDA decision By Investing.com - Investing.com India
VERAVera Therapeutics Inc Short Interest - Finviz
Is Vera Therapeutics, Inc. (VERA) A Good Stock To Buy Now? - Yahoo Finance
Vera Therapeutics updates kidney disease pipeline as investors weigh long-term potential - AD HOC NEWS
FDA Progress Could Send This Biotech Stock Soaring To New Heights - Yahoo Finance
Vera Therapeutics (VERA) Declines as Biotech Sector Faces HeadwindsJelly Roll Trade - dars.gov.et
7 FDA decisions to watch for in Q3 - BioSpace
$Vera Therapeutics (VERA.US)$ - Moomoo
A Quick Look at Today's Ratings for Vera Therapeutics(VERA.US), With a Forecast Between $56 to $90 - Moomoo
VERA Forecast — Price Target — Prediction for 2027 - TradingView
Vera Therapeutics, Inc. Class A Actuals & Estimates (NASDAQ:VERA) - TradingView
Vera Therapeutics Inc (VERA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Raymond James Maintains Vera Therapeutics(VERA.US) With Buy Rating - Moomoo
Form 4 Vera Therapeutics Inc For: 24 June By Investing.com - Investing.com Nigeria
Vera Therapeutics president and CEO Fordyce Marshall sells $701,769 in stock - Investing.com
Vera Therapeutics Insider Sold Shares Worth $701,769, According to a Recent SEC Filing - marketscreener.com
Vera Therapeutics (VERA) CEO sells 18,500 shares under 10b5-1 plan - Stock Titan
Form 144 Vera Therapeutics For: 23 June By Investing.com - Investing.com Australia
VERA (NASDAQ: VERA) plans resale of 74,000 shares via option exercise - Stock Titan
3 biotech firms with major potential catalysts in the coming months - MSN
3 Biotech Firms With Major Potential Catalysts in the Coming Months - MarketBeat
Vera Therapeutics (VERA) Is Up 10.7% After Accelerated FDA Timeline For Atacicept IgAN FilingHas The Bull Case Changed? - simplywall.st
Vera Therapeutics Inc (VERA) Institutional Confidence - TradingKey
(VERA) Risk Channels and Responsive Allocation - Stock Traders Daily
Vera Therapeutics Inc (VERA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Vera Therapeutics Inc (VERA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Vera Therapeutics Inc (VERA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Vera Therapeutics Inc (VERA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Vera Therapeutics stock gains 4.13% as Official VeraTx promotes new IgANime accessory features - Traders Union
Vera Therapeutics Inc (VERA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Vera Therapeutics Inc (VERA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Vera Therapeutics Inc (VERA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Vera Therapeutics (VERA) Appears Attractive After Latest FDA Agreement - Insider Monkey
1.17%
2.48%
자본화:
|
볼륨(24시간):